Markers of Arrhythmogenic Risk in Hypertensive Subjects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|28|3062-3073

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.28, 2011-09, pp. : 3062-3073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 995-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Statins on Novel Risk Markers

By Cignarella Andrea   Bolego Chiara   Paoletti Rodolfo  

Cardiovascular Drugs and Therapy, Vol. 17, Iss. 4, 2003-07 ,pp. : 361-366

Springer Publishing Company

Access to resources Recommend Favorite

Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 566-569

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Risk in Obese Hypertensive Patients Taking Various Antihypertensive Drugs

By Schindler Christoph  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 707-717

Adis International

Access to resources Recommend Favorite

Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 8-11

Adis International

Access to resources Recommend Favorite